CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria

Summary

Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical R&D. Austria was ranked sixth globally in terms of healthcare spending (11.1% of GDP). In 2016, the healthcare spending increased to 11.2% of the GDP and per capita spending was $5,227.The value of the Austrian pharmaceutical market value increased from €2.48 billion in 2010 to €2.87 billion in 2017, at a CAGR of 2%.

The aging population, rapid advances in new treatment options, robust healthcare system, high focus on R&D and change in demographics are expected to drive the growth of the pharmaceutical market. However, generic substitution and shortage of specialized staff act as a major barrier for the pharmaceutical market.

On the other hand, Austrian Medical Device market was valued at $1.63 billion in 2010 and increased to $1.95 billion in 2017.The main segments were nephrology and urology devices, orthopedic devices, ophthalmic devices, cardiovascular devices, and in vitro diagnostics. Medical device innovations to provide optimal, quick and affordable patient care in Austria are in the pipeline for years to come.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria, report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
• Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, Merck, Sanofi and Gerot Lannach) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche, DePuy and Sanochemia Pharmazeutika)
• Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Austria
• Porter’s five forces analysis for pharmaceutical and medical devices market of Austria
• An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
• Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
• An overview of the opportunities for and challenges to growth in the Austrian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Austrian healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
• Identify, understand, and capitalize on the opportunities and challenges in the Austrian healthcare market.